IBT Plus Semaglutide Slashed Pounds, CVD Risk

(MedPage Today) -- Adding a GLP-1 receptor agonist to intensive behavioral therapy (IBT) helped bolster weight loss, the phase III STEP 3 trial found.
Among 611 adults with overweight or obesity, those who added 2.4 mg of once-weekly subcutaneous...